AU2002221521A1 - Immunotherapeutic combinations for the treatment of tumors - Google Patents

Immunotherapeutic combinations for the treatment of tumors

Info

Publication number: AU2002221521A1
Authority: AU; Australia
Prior art keywords: tumors; treatment; immunotherapeutic combinations; immunotherapeutic; combinations
Prior art date: 2000-12-08
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

AU2002221521A

Other versions

AU2002221521B2 (en

Inventor

Irene Beausoleil Delgado

Tania Crombet Ramos

Gisela Maria Gonzalez Marinello

Rolando Perez Rodriguez

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Centro de Immunologia Molecular

Original Assignee

Centro de Immunologia Molecular

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-12-08

Filing date

2001-12-06

Publication date

2002-08-22

2000-12-08 Priority claimed from CU20000287A external-priority patent/CU22979A1/en

2001-12-06 Application filed by Centro de Immunologia Molecular filed Critical Centro de Immunologia Molecular

2002-08-22 Publication of AU2002221521A1 publication Critical patent/AU2002221521A1/en

2007-01-04 Application granted granted Critical

2007-01-04 Publication of AU2002221521B2 publication Critical patent/AU2002221521B2/en

2021-12-06 Anticipated expiration legal-status Critical

Status Ceased legal-status Critical Current

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
CU287/00		2000-12-08
CU20000287A CU22979A1 (en)	2000-12-08	2000-12-08	IMMUNOTHERAPEUTIC COMBINATION FOR THE TREATMENT OF TUMORS OVER-EXPRESSING RECEPTORS WITH KINASE ACTIVITY IN TYPOSINE WASTE
PCT/CU2001/000012 WO2002045747A1 (en)	2000-12-08	2001-12-06	Immunotherapeutic combinations for the treatment of tumors

Publications (2)

Publication Number	Publication Date
AU2002221521A1 true AU2002221521A1 (en)	2002-08-22
AU2002221521B2 AU2002221521B2 (en)	2007-01-04

Family

ID=40261022

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
AU2152102A Pending AU2152102A (en)	2000-12-08	2001-12-06	Immunotherapeutic combinations for the treatment of tumors
AU2002221521A Ceased AU2002221521B2 (en)	2000-12-08	2001-12-06	Immunotherapeutic combinations for the treatment of tumors

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
AU2152102A Pending AU2152102A (en)	2000-12-08	2001-12-06	Immunotherapeutic combinations for the treatment of tumors

Country Status (26)

Country	Link
US (2)	US20020160014A1 (en)
EP (2)	EP2005996A3 (en)
JP (2)	JP2005519023A (en)
KR (1)	KR20030064416A (en)
CN (1)	CN1326566C (en)
AR (1)	AR031641A1 (en)
AT (1)	ATE403438T1 (en)
AU (2)	AU2152102A (en)
BR (1)	BR0116010A (en)
CA (1)	CA2431199C (en)
CU (1)	CU22979A1 (en)
CY (1)	CY1108474T1 (en)
DE (1)	DE60135248D1 (en)
DK (1)	DK1350521T3 (en)
EA (1)	EA007381B1 (en)
ES (1)	ES2311036T3 (en)
HK (1)	HK1073244A1 (en)
MX (1)	MXPA03005030A (en)
MY (1)	MY138833A (en)
NZ (1)	NZ526284A (en)
PE (1)	PE20020695A1 (en)
PT (1)	PT1350521E (en)
SI (1)	SI1350521T1 (en)
UY (1)	UY27058A1 (en)
WO (1)	WO2002045747A1 (en)
ZA (1)	ZA200304415B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7507724B2 (en) *	2001-01-16	2009-03-24	Sloan-Kettering Institute For Cancer Research	Therapy-enhancing glucan
EP1493445A1 (en) *	2003-07-04	2005-01-05	Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.	Inhibition of stress-induced ligand-dependent EGFR activation
CU23297A1 (en) *	2004-11-16	2008-07-24	Ct De Inmunologa A Molecular	IMMUNOTHERAPY / 00UTICAL FORMULATIONS FOR THE INDUCTION OF BLOCKING AUTHORTIC BODIES OF THE INTERLEUCINE-2 UNION TO ITS RECEIVER. ITS USE IN THE TREATMENT OF CÃ NCER
US8323644B2 (en) *	2006-01-17	2012-12-04	Sloan-Kettering Institute For Cancer Research	Therapy-enhancing glucan
US20090053221A1 (en) *	2006-01-17	2009-02-26	Cheung Nai-Kong V	Immune response enhancing glucan
KR101493779B1 (en) *	2006-10-12	2015-02-16	츄가이 세이야꾸 가부시키가이샤	Diagnosis and treatment of cancer using anti-ereg antibody
CU23652A1 (en) *	2007-06-29	2011-05-27	Centro Inmunologia Molecular	HOMOGENOUS VACCINE COMPOSITION FOR THE TREATMENT OF CANCER AND ITS METHOD OF OBTAINING
US8642035B2 (en)	2008-01-17	2014-02-04	Irm Llc	Anti-TrkB antibodies
EP2436397B1 (en)	2009-05-29	2017-05-10	Chugai Seiyaku Kabushiki Kaisha	Pharmaceutical composition containing antagonist of egf family ligand as component
WO2012018260A1 (en) *	2010-08-05	2012-02-09	Universiteit Utrecht Holding B.V.	Epidermal growth factor receptor targeted immune therapy
TWI593705B (en)	2011-12-28	2017-08-01	Chugai Pharmaceutical Co Ltd	Humanized anti-epiregulin antibody and cancer therapeutic agent containing the antibody as an active ingredient
EP3583113A4 (en)	2017-02-17	2020-08-26	George Todaro	Use of tgf alpha for the treatment of diseases and disorders

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CU22545A1 (en) *	1994-11-18	1999-03-31	Centro Inmunologia Molecular	OBTAINING A CHEMICAL AND HUMANIZED ANTIBODY AGAINST THE RECEPTOR OF THE EPIDERMAL GROWTH FACTOR FOR DIAGNOSTIC AND THERAPEUTIC USE
JPH01221326A (en) *	1988-02-29	1989-09-04	Toyo Jozo Co Ltd	Cytotoxic agent against malignant tumorous cell
US5705157A (en) *	1989-07-27	1998-01-06	The Trustees Of The University Of Pennsylvania	Methods of treating cancerous cells with anti-receptor antibodies
EP0586002B1 (en) *	1992-08-18	2000-01-19	CENTRO de IMMUNOLOGIA MOLECULAR	Monoclonal antibodies recognizing the epidermal growth factor receptor, cells and methods for their production and compositions containing them
CA2261433A1 (en) *	1993-12-09	1995-06-10	Belinda Sanchez Ramirez	Composition comprising autologous epidermal growth factor
CA2137639C (en) *	1993-12-09	1999-01-26	Agustin B. L. Davila	Vaccine composition comprising autologous epidermal growth factor or a fragment or a derivate thereof having anti-tumor activity and use thereof in the therapy of malignant diseases
CU22615A1 (en) *	1994-06-30	2000-02-10	Centro Inmunologia Molecular	PROCEDURE FOR OBTAINING LESS IMMUNOGENIC MONOCLONAL ANTIBODIES. MONOCLONAL ANTIBODIES OBTAINED
NZ511550A (en) *	1997-05-12	2005-03-24	Aphton Corp	CCK-B/gastrin receptor inhibitors for the treatment of tumors
US20030219380A1 (en) *	1997-11-07	2003-11-27	Annie Fong	Method of determining an efficacious dose of a drug
CA2330212A1 (en) *	1998-05-08	1999-11-18	Sloan-Kettering Institute For Cancer Research	Compositions and methods for active vaccination
CN1314917A (en) *	1998-05-15	2001-09-26	伊姆克罗尼系统公司	Treatment of human tumors with radiation and inhibitors of growth factor receptor tyrosine kinase
US6498181B1 (en) *	1999-01-06	2002-12-24	Maxim Pharmaceuticals	Synergistic tumorcidal response induced by histamine
JP2003532740A (en) *	2000-05-05	2003-11-05	アフトンコーポレーション	Chimeric peptide immunogen
CU23077A1 (en) *	2000-12-06	2005-08-17	Centro Inmunologia Molecular	VACCINE COMPOSITION CONTAINING TRANSFORMING GROWTH FACTOR (TGF-ALFA). ITS USE IN MALIGNAL DISEASE THERAPY

2000
- 2000-12-08 CU CU20000287A patent/CU22979A1/en unknown
2001
- 2001-11-29 PE PE2001001203A patent/PE20020695A1/en not_active Application Discontinuation
- 2001-12-05 MY MYPI20015556A patent/MY138833A/en unknown
- 2001-12-06 WO PCT/CU2001/000012 patent/WO2002045747A1/en active IP Right Grant
- 2001-12-06 EP EP08161862A patent/EP2005996A3/en not_active Withdrawn
- 2001-12-06 AU AU2152102A patent/AU2152102A/en active Pending
- 2001-12-06 AU AU2002221521A patent/AU2002221521B2/en not_active Ceased
- 2001-12-06 ES ES01999388T patent/ES2311036T3/en not_active Expired - Lifetime
- 2001-12-06 EP EP01999388A patent/EP1350521B1/en not_active Expired - Lifetime
- 2001-12-06 CA CA2431199A patent/CA2431199C/en not_active Expired - Fee Related
- 2001-12-06 KR KR10-2003-7007630A patent/KR20030064416A/en active Search and Examination
- 2001-12-06 MX MXPA03005030A patent/MXPA03005030A/en active IP Right Grant
- 2001-12-06 DE DE60135248T patent/DE60135248D1/en not_active Expired - Lifetime
- 2001-12-06 EA EA200300646A patent/EA007381B1/en not_active IP Right Cessation
- 2001-12-06 UY UY27058A patent/UY27058A1/en unknown
- 2001-12-06 CN CNB018216854A patent/CN1326566C/en not_active Expired - Fee Related
- 2001-12-06 AT AT01999388T patent/ATE403438T1/en active
- 2001-12-06 PT PT01999388T patent/PT1350521E/en unknown
- 2001-12-06 JP JP2002547530A patent/JP2005519023A/en active Pending
- 2001-12-06 DK DK01999388T patent/DK1350521T3/en active
- 2001-12-06 NZ NZ526284A patent/NZ526284A/en not_active IP Right Cessation
- 2001-12-06 BR BR0116010-9A patent/BR0116010A/en not_active IP Right Cessation
- 2001-12-06 SI SI200130873T patent/SI1350521T1/en unknown
- 2001-12-07 US US10/005,341 patent/US20020160014A1/en not_active Abandoned
- 2001-12-07 AR ARP010105686A patent/AR031641A1/en not_active Application Discontinuation
2003
- 2003-06-05 ZA ZA200304415A patent/ZA200304415B/en unknown
2005
- 2005-07-11 HK HK05105840A patent/HK1073244A1/en not_active IP Right Cessation
2006
- 2006-04-20 US US11/407,103 patent/US7744871B2/en not_active Expired - Lifetime
2008
- 2008-11-03 CY CY20081101242T patent/CY1108474T1/en unknown
2010
- 2010-03-23 JP JP2010066088A patent/JP2010150286A/en not_active Abandoned

Publication	Publication Date	Title
AU2001227966A1 (en)	2001-07-31	Methods for treating tumors
AU2001272849A1 (en)	2002-01-21	Composition for the treatment of osteoarthritis
AU2002350235A1 (en)	2003-06-10	Combination bacteriolytic therapy for the treatment of tumors
AU2001282717A1 (en)	2002-02-13	Cancer treatment by combination therapy
AU2002223827A1 (en)	2002-05-27	Well treatment
AU2002348135A1 (en)	2003-05-12	Methods for the treatment of addiction
AU2935200A (en)	2000-11-17	Compounds for the treatment of obesity
AU2001255602A1 (en)	2001-11-12	Methods for treating bone tumors
AU2001272852A1 (en)	2002-01-21	Composition for the treatment of migraine
AU2002308347A1 (en)	2003-04-10	Immunotherapeutic combinations for the treatment of tumours that overexpress gangliosides
AU2000258650A1 (en)	2001-11-20	2-piperidone compounds for the treatment of cancer
EP1442062A4 (en)	2005-11-09	Methods for the treatment of carcinoma
AU2002221521A1 (en)	2002-08-22	Immunotherapeutic combinations for the treatment of tumors
AU2002217866A1 (en)	2002-05-15	Geldanamycin derivatives useful for the treatment of cancer
AU2001290165A1 (en)	2002-03-26	Components of canola for the treatment of cancer
AU2152102A (en)	2002-06-18	Immunotherapeutic combinations for the treatment of tumors
AU8322401A (en)	2002-02-18	Indole compounds useful for the treatment of cancer
AU2001293891A1 (en)	2002-04-15	New combination for the treatment of asthma
AU2001253568A1 (en)	2001-10-30	Lipopolysaccharide-conjugate vaccine for sepsis treatment
AU2002239431A1 (en)	2002-05-27	Compositions and methods for the therapy and diagnosis of ovarian cancer
HUP0101947A3 (en)	2001-12-28	Combination for the treatment of tumors
AU2001285156A1 (en)	2002-03-04	Combination therapy for the treatment of migraine
AU2002304883A1 (en)	2003-05-08	Device for the treatment of tumours
AU2001257325A1 (en)	2001-11-12	Cancer treatment
AU2001289127A1 (en)	2002-04-02	Tumor treatment